Abstract:ABSTRACT We recently found that a new pathogenic chimeric simian-human immunodeficiency virus (SHIV) elicited heterologous human immunodeficiency virus type-1 (HIV-1) neutralizing antibodies (nAbs) in therapy-naïve young rhesus macaques (RMs) following neonatal SHIV infection. Moreover, a subset of the SHIV-infected young RMs spontaneously controlled viremia. Here we evaluated humoral and cellular immunity and plasma biomarkers associated with spontaneous viremia suppression in a new model of young SHIV-infected RMs that generated heterologous HIV-1 nAbs independent of viremia control to gain insights into pediatric immunity that may be harnessed by appropriate therapies in HIV-1-infected infants and children. We determined the levels of 31 plasma analytes (cytokines, chemokines, and growth factors) in SHIV-infected RMs over the course of infection and found that six analytes with chemoattractant or pro-inflammatory activities had significantly lower levels in plasma of RMs that controlled viremia compared to non-controllers. Single-cell transcriptomics of blood-derived immune cells demonstrated that RMs with viremia control had upregulated genes associated with immune activation and cytotoxic functions, whereas non-controllers had upregulated genes associated with immune cell exhaustion and dysfunction. In addition to CD8 T and natural killer cells, monocytes with upregulation of inhibitory genes previously reported only in cytotoxic cells constituted the immunologic environment associated with viremia suppression. These data implicated a complex immunologic milieu of viremia suppression that is not fully defined in pediatric subjects. Understanding immune cell subsets that may be harnessed to control viremia will provide insights into future designs of HIV-1 therapeutic strategies. IMPORTANCE Despite the advent of highly active anti-retroviral therapy, people are still dying from HIV-related causes, many of whom are children, and a protective vaccine or cure is needed to end the HIV pandemic. Understanding the nature and activation states of immune cell subsets during infection will provide insights into the immunologic milieu associated with viremia suppression that can be harnessed via therapeutic strategies to achieve a functional cure, but these are understudied in pediatric subjects. We evaluated humoral and adaptive host immunity associated with suppression of viremia in rhesus macaques infected soon after birth with a pathogenic SHIV. The results from our study provide insights into the immune cell subsets and functions associated with viremia control in young macaques that may translate to pediatric subjects for the design of future anti-viral strategies in HIV-1-infected infants and children and contribute to an understudied area of HIV-1 pathogenesis in pediatric subjects.

Repressive Effect of Primary Virus Replication on Superinfection Correlated with Gut-Derived Central Memory CD4(+) T Cells in SHIV-infected Chinese Rhesus Macaques.

Partial protection of SHIV-infected Chinese rhesus macaques against super-infection with heterologous SHIV isolate.

Functional effector memory T cells contribute to protection from superinfection with heterologous simian immunodeficiency virus or simian-human immunodeficiency virus isolates in Chinese rhesus macaques

Experimental Infection of SHIVSF162p3 in Rhesus Macaques: Correlation Analysis of the Viral RNA Levels in the Acute Phase and the Distribution of CD4+ T Cell Subsets in the Chronic Phase

Cross-protection against reinfection of simian-human immunodeficiency virus(SHIV)in Chinese macaques vaccinated with different types of SHIV

Does Mucosal B1 Activation Result in the Accumulation of Peak IgM During Chronic Intrarectal SIVmac239 Exposure to Protect Chinese-Origin Rhesus Macaques From Disease Progression?

Enhanced innate antiviral gene expression, IFN-α, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection

The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.

Identification of Unequally Represented Founder Viruses Among Tissues in Very Early SIV Rectal Transmission.

Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection

Efficient Repeated Low-Dose Intravaginal Infection with SHIVSF162p3 in Chinese-Origin Rhesus Macaques

Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques.

Elevated Frequency of CD1c+ Myeloid Dendritic Cells in the Peripheral Blood Mononuclear Cells of Simian/human Immunodeficiency Virus (SHIV) and Simian Immunodeficiency Virus (SIV) Repeatedly Infected Chinese Rhesus Macaques.

Correlation of Central Memory Cd4(+) T-Cell Decrease in the Peripheral Blood with Disease Progression in Sivmac251-Infected Chinese Rhesus Macaques

Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques

Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques

Title Acute infection of chinese macaques by a CCR 5-tropic SHIVcarrying a primary HIV-1 subtype B ' envelope

Acute Infection of Chinese Macaques by a CCR5-tropic SHIV Carrying a Primary HIV-1 Subtype B' Envelope.

Immunologic And Virologic Mechanisms For Partial Protection From Intravenous Challenge By An Integration-Defective Siv Vaccine

Subsequent Malaria Enhances Virus-Specific T Cell Immunity in SIV-infected Chinese Rhesus Macaques

Serial passage of clade C SHIV-XJ02170 in Chinese origin Rhesus macaques